Alix Marduel Corcept Therapeutics Inc

As of November 13, 2008


What is Alix Marduel's Net Worth?

The current estimated net worth of Corcept Therapeutics Inc's Alix Marduel is estimated to be about $94.09M . Alix Marduel owns about 166,491 units of Corcept Therapeutics Inc common stock. In the last 4 years at Corcept Therapeutics Inc, Alix Marduel has sold an estimated value of $0 worth.

What is Alix Marduel's Past Insider Trading?

Alix Marduel's largest purchase order was 1,059,135 units , worth over $2.93M on March 26, 2008. In total, Alix Marduel has made about 7 transactions over 4 years of their time at Corcept Therapeutics Inc. Alix Marduel usually trades in August and April, with the busiest year in 2007.

ALTA BIOPHARMA PARTNERS II LP, ALIX MARDUEL, JEAN DELEAGE, FARAH CHAMPSI, ALTA BIOPHARMA MANAGEMENT II LLC, ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC, ALTA PARTNERS II INC

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Alix Marduel's' Mailing Address?

  • Mailing address is One Embarcadero Center Suite 3700 San Francisco CA 94111 CA

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 - $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 - $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 - $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 - $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 - $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 - $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 - $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 - $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 - $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

What are Corcept Therapeutics Inc's Past Insider Trades?

Corcept Therapeutics Inc's most recent insider trade came on May 19, 2022 by Gary Charles who sold 35,000 units worth $684.4K . In the last 18 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $166.04M and bought an estimated value of $184.22M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director .

CORCEPT THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1